← Eichor
Study identifier: NCT07354438 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Assessing the Effect of an Antioxidant-Rich Diet on Metabolic Syndrome Risk Using the Dietary Antioxidant Index

Condition: Metabolic Syndrome Risk Factors  ·  Sponsor: University of Veterinary and Animal Sciences, Lahore - Pakistan

PhaseNA
Planned participants55
Who can joinAll sexes, 18 Years to 45 Years
Healthy volunteersNo

About this study

Metabolic syndrome (MetS) is a cluster of metabolic disorders characterized by elevated levels of blood glucose, hypertension, dyslipidemia, and abdominal obesity. Globally, it is a major public health concern. International studies have linked higher Dietary Antioxidant Index with reduced risk of MetS, as antioxidants play a role in lowering the risk of MetS by reducing oxidative stress, a key contributor to its pathophysiology. Exploring this link in Pakistan can provide valuable insights for dietary strategies to reduce the risk of MetS.

This description comes directly from the study's public registry record.

Talk to the study team

Anaum Javed, PG  ·  +92-3040370308  ·  anaumjaved768@gmail.com

Qaisar Raza, Ph.D  ·  +92-3002479044  ·  qaiasr.raza@uvas.edu.pk

Always discuss trial participation with your own doctor first.

Locations (1)

University of Veterinary & Animal Sciences, Lahore PakistanLahore, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07354438